Literature DB >> 19309414

The challenge of cross-cultural, multi-national research: potential benefits in the functional gastrointestinal disorders.

A D Sperber1.   

Abstract

The increasing interest in research in irritable bowel syndrome (IBS) and other functional gastrointestinal disorders (FGIDs), taken together with the growing sophistication of communication technology, makes cross-cultural, multi-national research a feasible endeavour. The aim of this study is to encourage collaborative cross-cultural studies in FGIDs by discussing relevant methodological issues, and by suggesting potential areas in which cross-cultural research can make a significant contribution to the understanding of FGIDs and to patient care. To this end, methodological issues related to cross-cultural research and competences required for its conduct are presented together with a critique of published studies and recommendations for future research in the area. The term 'cross-cultural' research in FGIDs is usually applied to the results of prevalence studies, for example comparative studies of IBS prevalence in different countries and ethnic groups. The validity of these comparisons is impacted negatively by the lack of uniformity in research methods. In addition to prevalence studies, cross-cultural research can make a significant contribution in areas such as molecular biology, genetics, psychosocial factors, symptom presentation, extra-intestinal comorbidity, diagnosis and treatment, determinants of disease severity, healthcare utilization, and health-related quality of life, all issues that can be affected by culture, ethnicity and race. Well-designed and implemented cross-cultural studies can advance our knowledge in many FGID-related areas ranging from epidemiology through psychosocial factors, pathophysiological mechanisms and therapeutics. These studies, conducted by investigators with competence in cross-cultural research methodology, can advance our understanding of the FGIDs and contribute to improved patient care.

Entities:  

Mesh:

Year:  2009        PMID: 19309414     DOI: 10.1111/j.1365-2982.2009.01276.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  10 in total

1.  Irritable bowel syndrome: a multidimensional disorder cannot be understood or treated from a unidimensional perspective.

Authors:  Ami D Sperber; Douglas A Drossman
Journal:  Therap Adv Gastroenterol       Date:  2012-11       Impact factor: 4.409

2.  Factors associated with irritable bowel syndrome symptoms in hemodialysis patients.

Authors:  Bartosz Fiderkiewicz; Alicja Rydzewska-Rosołowska; Michał Myśliwiec; Magdalena Birecka; Bożenna Kaczanowska; Grażyna Rydzewska; Andrzej Rydzewski
Journal:  World J Gastroenterol       Date:  2011-04-21       Impact factor: 5.742

3.  Epidemiology of uninvestigated and functional dyspepsia in Asia: facts and fiction.

Authors:  Uday C Ghoshal; Rajan Singh; Full-Young Chang; Xiaohua Hou; Benjamin Chun Yu Wong; Udom Kachintorn
Journal:  J Neurogastroenterol Motil       Date:  2011-07-13       Impact factor: 4.924

4.  Irritable bowel syndrome and psychiatric disorders in pakistan: a case control study.

Authors:  Amna Subhan Butt; Mohammad Salih; Wasim Jafri; Javed Yakoob; Mohammad Wasay; Saeed Hamid
Journal:  Gastroenterol Res Pract       Date:  2012-02-28       Impact factor: 2.260

5.  Asian consensus report on functional dyspepsia.

Authors:  Hiroto Miwa; Uday C Ghoshal; Sutep Gonlachanvit; Kok-Ann Gwee; Tiing-Leong Ang; Full-Young Chang; Kwong Ming Fock; Michio Hongo; Xiaohua Hou; Udom Kachintorn; Meiyun Ke; Kwok-Hung Lai; Kwang Jae Lee; Ching-Liang Lu; Sanjiv Mahadeva; Soichiro Miura; Hyojin Park; Poong-Lyul Rhee; Kentaro Sugano; Ratha-Korn Vilaichone; Benjamin Cy Wong; Young-Tae Bak
Journal:  J Neurogastroenterol Motil       Date:  2012-04-09       Impact factor: 4.924

6.  Development, Translation and Validation of Enhanced Asian Rome III Questionnaires for Diagnosis of Functional Bowel Diseases in Major Asian Languages: A Rome Foundation-Asian Neurogastroenterology and Motility Association Working Team Report.

Authors:  Uday C Ghoshal; Kok-Ann Gwee; Minhu Chen; Xiao R Gong; Nitesh Pratap; Xiaohua Hou; Ari F Syam; Murdani Abdullah; Young-Tae Bak; Myung-Gyu Choi; Sutep Gonlachanvit; Andrew S B Chua; Kuck-Meng Chong; Kewin T H Siah; Ching-Liang Lu; Lishou Xiong; William E Whitehead
Journal:  J Neurogastroenterol Motil       Date:  2015-01-01       Impact factor: 4.924

7.  Translation and Validation of Enhanced Asian Rome III Questionnaires in Bengali Language for Diagnosis of Functional Gastrointestinal Disorders.

Authors:  M Masudur Rahman; Uday C Ghoshal; A H M Rowshon; Faruque Ahmed; Md Golam Kibria; Mahmud Hasan; Kok-Ann Gwee; William E Whitehead
Journal:  J Neurogastroenterol Motil       Date:  2016-04-30       Impact factor: 4.924

8.  Economic burden of irritable bowel syndrome in China.

Authors:  Fang Zhang; Wei Xiang; Chun-Yan Li; Shu-Chuen Li
Journal:  World J Gastroenterol       Date:  2016-12-21       Impact factor: 5.742

9.  Global prevalence and burden of meal-related abdominal pain.

Authors:  Esther Colomier; Chloé Melchior; Joost P Algera; Jóhann P Hreinsson; Stine Störsrud; Hans Törnblom; Lukas Van Oudenhove; Olafur S Palsson; Shrikant I Bangdiwala; Ami D Sperber; Jan Tack; Magnus Simrén
Journal:  BMC Med       Date:  2022-02-17       Impact factor: 8.775

10.  Factors influencing treatment outcome in patients with gastroesophageal reflux disease: outcome of a prospective pragmatic trial in Asian patients.

Authors:  Khean Lee Goh; Kee Don Choi; Myung-Gyu Choi; Tsai-Yuan Hsieh; Hwoon-Yong Jung; Han-Chung Lien; Jayaram Menon; Steven Mesenas; Hyojin Park; Bor-Shyang Sheu; Justin Cy Wu
Journal:  BMC Gastroenterol       Date:  2014-09-09       Impact factor: 3.067

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.